Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market Report by Application Disease Product, Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The Global Human Microbiome Market is anticipated to experience a significant growth spurt, reaching a valuation of US$ 3.05 billion by 2032 from its US$ 0.72 billion status in 2023.
This robust growth, expected to proceed at a CAGR of 17.48% during the forecast period of 2023-2032, is attributed to a rising awareness of the human microbiome's role in health and disease prevention. The escalating prevalence of lifestyle diseases, an increasing geriatric population, and substantial governmental funding for microbiome projects have been identified as key factors contributing to market growth.
A growing body of research indicates the human microbiome's significant potential to revolutionize the approach to various health conditions, including type 2 diabetes, obesity, autoimmune disorders, and certain forms of cancer. As lifestyle-related diseases surge globally, the market is responding with innovative solutions to harness the healing and protective power of the human microbiome. For instance, connections between gut microbial diversity and improved insulin resistance offer promising avenues for diabetes management.
Response to the COVID-19 Pandemic
The COVID-19 pandemic has led to a spike in interest and awareness regarding the therapeutic potential of the human microbiome. Companies such as Persephone Biosciences Inc. have stepped forward with immune-boosting therapeutics and diagnostic tests aimed at predicting severe complications from the virus, reflecting a significant pivot towards microbiome-focused solutions within the healthcare market.
Strategic Collaborations and Regulatory Milestones
High-profile collaborations, such as that between Seres Therapeutics Inc. and Nestlé Health Science, seek to pave new paths in the marketplace. These partnerships aim to bring novel therapeutic offerings to fruition, potentially reshaping the treatment landscape for recurrent Clostridioides difficile infections and other health conditions.
Regional Market Insights
The North American human microbiome market, with the United States at the forefront, is expected to expand vigorously. This expansion is fueled by a rise in cancer incidence and the FDA's nod to novel therapies, like those developed by 4D Pharma plc, designed to address neurological disorders such as Parkinson's disease. Innovations in regulatory frameworks and research endeavors are tipped to be accelerants for the North American market's growth.
Key Market Players & Developments
In a market characterized by dynamic innovation and strategic ventures, major players such as DuPont, Evelo Biosciences Inc., and Finch Therapeutics Group Inc. continue to lead. Innovative product launches, strategic partnerships, and investments in R&D are some of the key strategies employed by these companies to maintain and bolster their market presence.
Conclusion
The Global Human Microbiome Market is on a trajectory of rapid growth, with potential impacts spanning across various medical fields and geographical regions. Through advanced research, strategic industry collaborations, and supportive regulatory environments, the market is poised for unprecedented expansion, further underlining the importance of the human microbiome in contemporary healthcare.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 210 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value (USD) in 2023 | $0.72 Billion |
| Forecasted Market Value (USD) by 2032 | $3.05 Billion |
| Compound Annual Growth Rate | 17.4% |
| Regions Covered | Global |
Company Profile: Overview, Recent Developments, Product Portfolio, Revenue
- DuPont
- Evelo Biosciences Inc.
- Finch Therapeutics Group Inc.
- Ginkgo Bioworks
- Seres Therapeutics
- AOBiome
- Astarte Medical
- Axial Biotherapeutics
Application - Global Human Microbiome Market breakup into 2 Viewpoints
- Therapeutics
- Diagnostics
Disease - Global Human Microbiome Market breakup into 7 Viewpoints
- Obesity
- Diabetes
- Autoimmune Disorders
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Other Diseases
Product - Global Human Microbiome Market breakup into 4 Viewpoints
- Probiotics
- Prebiotics
- Symboitics
- Other Products
Geography - Global Human Microbiome breakup of 25 Countries
- North America
- United States
- Canada
- Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Turkey
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- New Zealand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
For more information about this report visit https://www.researchandmarkets.com/r/4x32hz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
